Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Wang

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Thorax|August 10, 2016
The obstructive sleep apnoea syndrome in adolescentsCarole L Marcus, Brendan T Keenan, Jingtao Huang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 14, 2016
Efficacy and Pharmacology of the NLRP3 Inflammasome Inhibitor CP-456,773 (CRID3) in Murine Models of Dermal and Pulmonary InflammationMichael J Primiano, Bruce A Lefker, Michael R Bowman, et al.
Molecular Cancer Therapeutics|November 18, 2021
Combination of Type I and Type II MET Tyrosine Kinase Inhibitors as Therapeutic Approach to Prevent ResistanceMagda Bahcall, Cloud P Paweletz, Yanan Kuang, et al.
Cancer Research|February 12, 2022
A Novel HER2-Selective Kinase Inhibitor Is Effective in HER2 Mutant and Amplified Non-Small Cell Lung CancerJieun Son, Jaebong Jang, Tyler S Beyett, et al.
Scientific Reports|October 7, 2023
A protein kinase C α and β inhibitor blunts hyperphagia to halt renal function decline and reduces adiposity in a rat model of obesity-driven type 2 diabetesJu Wang, Agustin Casimiro-Garcia, Bryce G Johnson, et al.
Cancer Immunology Research|September 23, 2018
A High-Throughput Immune-Oncology Screen Identifies EGFR Inhibitors as Potent Enhancers of Antigen-Specific Cytotoxic T-lymphocyte Tumor Cell KillingPatrick H Lizotte, Ruey-Long Hong, Troy A Luster, et al.
Cancer Discovery|May 17, 2019
Single and Dual Targeting of Mutant EGFR with an Allosteric InhibitorCiric To, Jaebong Jang, Ting Chen, et al.
Medrxiv : the Preprint Server for Health Sciences|January 20, 2021
Intermediate-dose anticoagulation, aspirin, and in-hospital mortality in COVID-19: a propensity score-matched analysisMatthew L Meizlish, George Goshua, Yiwen Liu, et al.
Cancer Cell|September 12, 2018
Overcoming Resistance to Dual Innate Immune and MEK Inhibition Downstream of KRASShunsuke Kitajima, Hajime Asahina, Ting Chen, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2026
Engineering Endogenous T Cell Receptors to Recognize Cancer Neoantigens Using a Hybrid Physics-AI ApproachJeffrey K Weber, Gyanu Parajuli, Stephen Wang, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Thorax|August 10, 2016
The obstructive sleep apnoea syndrome in adolescentsCarole L Marcus, Brendan T Keenan, Jingtao Huang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 14, 2016
Efficacy and Pharmacology of the NLRP3 Inflammasome Inhibitor CP-456,773 (CRID3) in Murine Models of Dermal and Pulmonary InflammationMichael J Primiano, Bruce A Lefker, Michael R Bowman, et al.
Molecular Cancer Therapeutics|November 18, 2021
Combination of Type I and Type II MET Tyrosine Kinase Inhibitors as Therapeutic Approach to Prevent ResistanceMagda Bahcall, Cloud P Paweletz, Yanan Kuang, et al.
Cancer Research|February 12, 2022
A Novel HER2-Selective Kinase Inhibitor Is Effective in HER2 Mutant and Amplified Non-Small Cell Lung CancerJieun Son, Jaebong Jang, Tyler S Beyett, et al.
Scientific Reports|October 7, 2023
A protein kinase C α and β inhibitor blunts hyperphagia to halt renal function decline and reduces adiposity in a rat model of obesity-driven type 2 diabetesJu Wang, Agustin Casimiro-Garcia, Bryce G Johnson, et al.
Cancer Immunology Research|September 23, 2018
A High-Throughput Immune-Oncology Screen Identifies EGFR Inhibitors as Potent Enhancers of Antigen-Specific Cytotoxic T-lymphocyte Tumor Cell KillingPatrick H Lizotte, Ruey-Long Hong, Troy A Luster, et al.
Cancer Discovery|May 17, 2019
Single and Dual Targeting of Mutant EGFR with an Allosteric InhibitorCiric To, Jaebong Jang, Ting Chen, et al.
Medrxiv : the Preprint Server for Health Sciences|January 20, 2021
Intermediate-dose anticoagulation, aspirin, and in-hospital mortality in COVID-19: a propensity score-matched analysisMatthew L Meizlish, George Goshua, Yiwen Liu, et al.
Cancer Cell|September 12, 2018
Overcoming Resistance to Dual Innate Immune and MEK Inhibition Downstream of KRASShunsuke Kitajima, Hajime Asahina, Ting Chen, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2026
Engineering Endogenous T Cell Receptors to Recognize Cancer Neoantigens Using a Hybrid Physics-AI ApproachJeffrey K Weber, Gyanu Parajuli, Stephen Wang, et al.
Pageof 3